MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET 2019-2027

MARKET OUTLOOK
The Middle East and Africa newborn screening market is estimated to grow in terms of revenue and proliferate with a CAGR of 13.49% over the forecasting period of 2019-2027, according to a study conducted by Triton.
The United Arab Emirates, Turkey, South Africa, Saudi Arabia and countries in rest of MEA together constitute the market for newborn screening in the Middle East and Africa region.
Economic factors hindering the adoption of newborn screening tests include the cost of care, lack of transport to receive care and loss of work. Other social factors include parents with poor education, long distance, lack of social support in hospital settings and families relying on traditional healers & other religious beliefs. As per the WHO, in most developing countries such as in the African region, maternal, newborn and child deaths occur at home due to delays in reaching the care they need. Babies with birth defects such as asphyxia, sepsis or other associated complications with premature birth can lose their lives within a day, hours or minutes in the absence of appropriate care. Thus, these socio-economic barriers are hindering the adoption of newborn screening tests, hence restraining the market growth.
COMPETITIVE OUTLOOK
The top key players in the market are BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Trivitron Healthcare, Cardinal Health, Inc., Waters Corporation, Medtronic Plc, Thermo Fisher Scientific, Inc., Natus Medical, Incorporated, SCIEX, Agilent Technologies, Inc., ZenTech S.A., PerkinElmer, Inc., GE Healthcare, Limited, NeoGen Labs Pvt. Ltd. and Masimo Corporation.

TABLE OF CONTENT
1. MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
2.2.2. GROWTH IN DRY BLOOD SPOT TEST
2.2.3. TECHNIQUES USED IN NEWBORN SCREENING TESTS
2.3. EVOLUTION & TRANSITION OF NEWBORN SCREENING
2.4. PORTER’S FIVE FORCE ANALYSIS
2.4.1. THREAT OF NEW ENTRANTS
2.4.2. THREAT OF SUBSTITUTE
2.4.3. BARGAINING POWER OF SUPPLIERS
2.4.4. BARGAINING POWER OF BUYERS
2.4.5. THREAT OF COMPETITIVE RIVALRY
2.5. KEY IMPACT ANALYSIS
2.5.1. RELIABILITY
2.5.2. COST
2.5.3. AVAILABILITY
2.5.4. TECHNOLOGICAL ADVANCEMENT
2.6. MARKET ATTRACTIVENESS INDEX
2.7. VENDOR SCORECARD
2.8. INDUSTRY COMPONENTS
2.8.1. RAW MATERIAL SUPPLIERS
2.8.2. MANUFACTURERS
2.8.3. DISTRIBUTORS
2.8.4. END-USERS
2.9. REGULATORY FRAMEWORK
2.10. INDUSTRY PLAYER POSITIONING
2.11. KEY MARKET STRATEGIES
2.11.1. PRODUCT LAUNCH
2.12. MARKET DRIVERS
2.12.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES
2.12.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
2.12.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
2.12.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
2.13. MARKET RESTRAINTS
2.13.1. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
2.14. MARKET OPPORTUNITIES
2.14.1. NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
2.14.2. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
2.14.3. INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
2.15. MARKET CHALLENGES
2.15.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
2.15.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL
3. NEWBORN SCREENING MARKET OUTLOOK - BY PRODUCT
3.1. NEWBORN SCREENING INSTRUMENTS
3.2. NEWBORN SCREENING REAGENTS & ASSAY KITS
4. NEWBORN SCREENING MARKET OUTLOOK - BY TEST TYPE
4.1. HEARING SCREEN TEST
4.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
4.3. DRY BLOOD SPOT TEST
5. NEWBORN SCREENING MARKET OUTLOOK - BY TECHNOLOGY
5.1. TANDEM MASS SPECTROMETRY
5.2. PULSE OXIMETRY
5.3. ENZYME-BASED ASSAYS
5.4. DNA-BASED ASSAYS
5.5. ELECTROPHORESIS
5.6. OTHERS
6. NEWBORN SCREENING MARKET - REGIONAL OUTLOOK
6.1. UNITED ARAB EMIRATES
6.2. TURKEY
6.3. SAUDI ARABIA
6.4. SOUTH AFRICA
6.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. SCIEX
7.2. BIOTEK INSTRUMENTS, INC.
7.3. BIO-RAD LABORATORIES, INC.
7.4. CARDINAL HEALTH, INC.
7.5. GE HEALTHCARE, LIMITED
7.6. AGILENT TECHNOLOGIES, INC.
7.7. MASIMO CORPORATION
7.8. NATUS MEDICAL, INCORPORATED
7.9. MEDTRONIC PLC
7.10. THERMO FISHER SCIENTIFIC, INC.
7.11. NEOGEN LABS PVT. LTD.
7.12. PERKINELMER, INC.
7.13. ZENTECH S.A.
7.14. WATERS CORPORATION
7.15. TRIVITRON HEALTHCARE
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY


LIST OF TABLES
TABLE 1: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 7: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)



LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: KEY BUYING IMPACT ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: INDUSTRY PLAYER POSITIONING IN 2018 (IN %)
FIGURE 5: FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017
FIGURE 6: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY NEWBORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY ENZYME BASED ASSAY, 2019-2027 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY DNA BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 18: UNITED ARAB EMIRATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 19: TURKEY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 20: SAUDI ARABIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 21: SOUTH AFRICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 22: REST OF MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)